CAR-T Cell Immunotherapy for HCC Targeting GPC3

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to preliminarily evaluate the safety and efficacy of CAR-T cell immunotherapy for GPC3 positive hepatocellular carcinoma.
Epistemonikos ID: 5eaba7315786188eebb5b16eaa89b75dc23b7e6e
First added on: May 12, 2024